402 related articles for article (PubMed ID: 28987560)
1. Outcomes of pelvic exenteration for recurrent and primary locally advanced rectal cancer.
Rottoli M; Vallicelli C; Boschi L; Poggioli G
Int J Surg; 2017 Dec; 48():69-73. PubMed ID: 28987560
[TBL] [Abstract][Full Text] [Related]
2. Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer.
Bhangu A; Ali SM; Brown G; Nicholls RJ; Tekkis P
Ann Surg; 2014 Feb; 259(2):315-22. PubMed ID: 23478530
[TBL] [Abstract][Full Text] [Related]
3. Survival after pelvic exenteration for T4 rectal cancer.
Kusters M; Austin KK; Solomon MJ; Lee PJ; Nieuwenhuijzen GA; Rutten HJ
Br J Surg; 2015 Jan; 102(1):125-31. PubMed ID: 25451182
[TBL] [Abstract][Full Text] [Related]
4. Total pelvic exenteration for primary and recurrent malignancies.
Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Impact of Intra-abdominal/Pelvic Inflammation After Radical Surgery for Locally Recurrent Rectal Cancer.
Tanaka M; Kanemitsu Y; Shida D; Ochiai H; Tsukamoto S; Nagino M; Moriya Y
Dis Colon Rectum; 2017 Aug; 60(8):827-836. PubMed ID: 28682968
[TBL] [Abstract][Full Text] [Related]
6. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
Gannon CJ; Zager JS; Chang GJ; Feig BW; Wood CG; Skibber JM; Rodriguez-Bigas MA
Ann Surg Oncol; 2007 Jun; 14(6):1870-7. PubMed ID: 17406945
[TBL] [Abstract][Full Text] [Related]
7. Determinants of survival following pelvic exenteration for primary rectal cancer.
Radwan RW; Jones HG; Rawat N; Davies M; Evans MD; Harris DA; Beynon J;
Br J Surg; 2015 Sep; 102(10):1278-84. PubMed ID: 26095525
[TBL] [Abstract][Full Text] [Related]
8. Pelvic exenteration for men with locally advanced rectal cancer: a morbidity analysis of complicated cases.
Hsu TW; Chiang FF; Chen MC; Wang HM
Asian J Surg; 2011 Jul; 34(3):115-20. PubMed ID: 22208686
[TBL] [Abstract][Full Text] [Related]
9. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
[No Abstract] [Full Text] [Related]
10. Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer.
Platt E; Dovell G; Smolarek S
Tech Coloproctol; 2018 Nov; 22(11):835-845. PubMed ID: 30506497
[TBL] [Abstract][Full Text] [Related]
11. Does radiotherapy of the primary rectal cancer affect prognosis after pelvic exenteration for recurrent rectal cancer?
Rombouts AJ; Koh CE; Young JM; Masya L; Roberts R; De-Loyde K; de Wilt JH; Solomon MJ
Dis Colon Rectum; 2015 Jan; 58(1):65-73. PubMed ID: 25489696
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of pelvic exenteration for locally advanced primary rectal cancer: Overall survival and quality of life.
Quyn AJ; Austin KK; Young JM; Badgery-Parker T; Masya LM; Roberts R; Solomon MJ
Eur J Surg Oncol; 2016 Jun; 42(6):823-8. PubMed ID: 26947962
[TBL] [Abstract][Full Text] [Related]
13. Utilization of interventional radiology in the postoperative management of patients after surgery for locally advanced and recurrent rectal cancer.
Llaguna OH; Calvo BF; Stitzenberg KB; Deal AM; Burke CT; Dixon RG; Stavas JM; Meyers MO
Am Surg; 2011 Aug; 77(8):1086-90. PubMed ID: 21944529
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic Pelvic Exenteration for Locally Advanced Rectal Cancer, Technique and Short-Term Outcomes.
Pokharkar A; Kammar P; D'souza A; Bhamre R; Sugoor P; Saklani A
J Laparoendosc Adv Surg Tech A; 2018 Dec; 28(12):1489-1494. PubMed ID: 29741977
[No Abstract] [Full Text] [Related]
15. Outcome of total pelvic exenteration for locally recurrent rectal cancer.
Ike H; Shimada H; Ohki S; Yamaguchi S; Ichikawa Y; Fujii S
Hepatogastroenterology; 2003; 50(51):700-3. PubMed ID: 12828064
[TBL] [Abstract][Full Text] [Related]
16. Role of pelvic exenteration in the management of locally advanced primary and recurrent rectal cancer.
Xin KY; Ng DW; Tan GH; Teo MC
J Gastrointest Cancer; 2014 Sep; 45(3):291-7. PubMed ID: 24563189
[TBL] [Abstract][Full Text] [Related]
17. Pelvic exenteration and composite sacral resection in the surgical treatment of locally recurrent rectal cancer.
Gawad W; Khafagy M; Gamil M; Fakhr I; Negm M; Mokhtar N; Lotayef M; Mansour O
J Egypt Natl Canc Inst; 2014 Sep; 26(3):167-73. PubMed ID: 25150132
[TBL] [Abstract][Full Text] [Related]
18. Surgery for locally recurrent rectal cancer.
Boyle KM; Sagar PM; Chalmers AG; Sebag-Montefiore D; Cairns A; Eardley I
Dis Colon Rectum; 2005 May; 48(5):929-37. PubMed ID: 15785880
[TBL] [Abstract][Full Text] [Related]
19. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies.
Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD; Austin KK
Dis Colon Rectum; 2014 Oct; 57(10):1153-61. PubMed ID: 25203370
[TBL] [Abstract][Full Text] [Related]
20. Surgical and Survival Outcomes Following Pelvic Exenteration for Locally Advanced Primary Rectal Cancer: Results From an International Collaboration.
PelvEx Collaborative
Ann Surg; 2019 Feb; 269(2):315-321. PubMed ID: 28938268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
